In a report released on November 29, Kerry Holford from Berenberg Bank maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.00. The company’s shares closed ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...

European Commission approves GSK’s fully liquid Menveo meningococcal vaccine: London, UK Friday, November 29, 2024, 11:00 Hrs [IST] GSK plc announced that the European Commissio ...

GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...

The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine ...

GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against ...

The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...

(Alliance News) - GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new single-vial, fully liquid presentation. In 2022, the ...

GSK's liquid meningitis vaccine Menveo has been approved by EU regulators, paving the way for a simpler vaccination process ...

GSK's liquid meningitis vaccine, Menveo, received approval from the European Commission to be sold in the European Union. The British pharmaceutical company said Wednesday that the fully liquid ...

North America Leads in Revenue Share with Robust Immunization Infrastructure while Asia-Pacific Drives Fastest Growth Fueled ...